EPIQ Partners’s VistaGen Therapeutics VTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-43,378
| Closed | -$1.15M | – | 84 |
|
|
2022
Q2 | $1.15M | Buy |
43,378
+4,666
| +12% | +$123K | 0.7% | 44 |
|
|
2022
Q1 | $1.44M | Buy |
38,712
+5,300
| +16% | +$197K | 0.77% | 45 |
|
|
2021
Q4 | $1.96M | Buy |
33,412
+2,875
| +9% | +$168K | 1.04% | 36 |
|
|
2021
Q3 | $2.51M | Sell |
30,537
-562
| -2% | -$46.2K | 1.16% | 33 |
|
|
2021
Q2 | $2.94M | Buy |
31,099
+1,700
| +6% | +$161K | 1.47% | 28 |
|
|
2021
Q1 | $1.88M | Buy |
+29,399
| New | +$1.88M | 1.08% | 36 |
|